MSPG

This small molecule is a selective antagonist of metabotropic glutamate (mGlu) receptors. It is a valuable research tool for investigating glutamatergic signaling in neurological and psychiatric disorders, facilitating both in vitro binding assays and in vivo behavioral studies.